Clinical Trial Update: Psychometric Properties of IntelliSpace Cognition [NA]

View source ↗

Summary

A completed clinical trials study evaluating psychometric properties of IntelliSpace Cognition in healthy individuals, with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Dysfunction in Healthy Individuals
• Cognitive Impairment

Snippet

Sponsor: Philips Electronics Nederland B.V. acting through Philips CTO organization | Conditions: Cognitive Functioning of Healthy Individuals | NA | Status: COMPLETED | Results posted: 2023-06-22